Skip to content

Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment

Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment: A Randomized Clinical Trial

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05883150
Enrollment
68
Registered
2023-05-31
Start date
2022-11-10
Completion date
2023-08-30
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Sedation

Brief summary

The aim of the current study is to compare the effect of intranasal versus nebulized route of administration of midazolam as moderate sedative agents in preschoolers undergoing dental treatment.

Interventions

All the drug solutions will be freshly prepared on the day of sedation session. Depending on the dosage calculated from the weight of each child The sedative drug, the dosage will be diluted with an equal volume by adding distilled water. The child will be seated in an upright position on the dental chair. Before placing the mask of the nebulizer, the child will be coached into proper breathing pattern

All the drug solutions will be freshly prepared on the day of sedation session. Depending on the dosage calculated from the weight of each child, For children who will receive midazolam using the atomization device attached to a three-ml syringe, the child sitting reclined in knee-to-knee position. Half of the dose will be sprayed in the right nostril and the other half will be sprayed in the left nostril to double the absorptive surface area by short and quick puffs

Sponsors

Nourhan M.Aly
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
3 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

* Frankl scale score 2. * ASA I or II physical status. * Dental intervention under local anesthesia not requiring more than 30 minutes. * No previous dental experience. * Parent/guardian's written consent.

Exclusion criteria

* Dental treatment indicated under general anesthesia. * Presence of facial or nasal deformities. * History of neurological or cognitive alterations. * Mouth breathers

Design outcomes

Primary

MeasureTime frameDescription
Behavior ratingthroughout the sedation sessionThis will be recorded using the Modified Houpt scale for behavior rating; Sleep, head/oral resistance, crying and overall behavior will be scored on a 6-point scale ranging from 1-6 with higher scores indicating better behavior

Secondary

MeasureTime frameDescription
Onset of sedationduring the sedation procedure (after drug administration until reaching satisfactory sedation)The time taken for sedative drugs to start their action will be recorded using a stopwatch
Level of sedationduring the sedation procedure (after drug administration until reaching satisfactory sedation)The level of sedation Agitated will be scored using a Five point sedation scale * Agitated - Clinging to parent/crying * Alert - Awake, not clinging to parent/no cry * Calm - Sitting or lying comfortably with eyes spontaneously open eyes spontaneously closed but responds * Drowsy: Comfortable with minor stimuli * Asleep: Eyes closed, arousable, does not respond to minor stimuli.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026